Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells

被引：0
|
作者：
Raquel T Lima
Luís M Martins
José E Guimarães
Clara Sambade
M Helena Vasconcelos
机构：
[1] IPATIMUP — Institute of Molecular Pathology and Immunology of the University of Porto,Department of Microbiology
[2] Cancer Research UK,undefined
[3] Faculty of Medicine of the University of Porto and Hospital S João,undefined
[4] Faculty of Pharmacy of the University of Porto,undefined
来源：
Cancer Gene Therapy | 2004年 / 11卷
关键词：
siRNAs; RNAi; Bcl-2; xIAP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Antiapoptotic genes such as bcl-2 or xIAP may be responsible for resistance to apoptosis induced by cytotoxic drugs. The aim of this study was to investigate if downregulation of bcl-2 or xIAP by RNA interference (RNAi) would sensitize MCF-7 cells to etoposide and doxorubicin. FITC-siRNAs uptake was verified by fluorescence microscopy and downregulation of Bcl-2 or XIAP was confirmed by Western Blotting. Both siRNAs reduced the number of viable cells and increased cellular apoptosis. Treatment with siRNAs followed by treatment with etoposide or doxorubicin further reduced the number of viable cells, when compared to either of the treatments alone. Therefore, downregulation of bcl-2 or xIAP by RNAi enhances the effects of etoposide and doxorubicin.
引用
收藏
页码：309 / 316
页数：7
相关论文
共 50 条
  • [1] Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
    Lima, RT
    Martins, SM
    Guimaraes, JE
    Sambade, C
    Vasconcelos, MH
    CANCER GENE THERAPY, 2004, 11 (05) : 309 - 316
  • [2] Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7
    Leung, LK
    Wang, TTY
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 55 (01) : 73 - 83
  • [3] Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells
    Kassi, E.
    Sourlingas, T. G.
    Spiliotaki, M.
    Papoutsi, Z.
    Pratsinis, H.
    Aligiannis, N.
    Moutsatsou, P.
    CANCER INVESTIGATION, 2009, 27 (07) : 723 - 733
  • [4] Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells
    Lin, Benrui
    Li, Dinuo
    Zhang, Lan
    PHARMAZIE, 2016, 71 (03): : 154 - 157
  • [5] Matrine inhibited proliferation and increased apoptosis in human breast cancer MCF-7 cells via upregulation of Bax and downregulation of Bcl-2
    Li, Haijun
    Li, Xiujuan
    Bai, Meiling
    Suo, Yueer
    Zhang, Guohui
    Cao, Xueyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14793 - 14799
  • [6] Genistein converts Bcl-2 into a proapoptotic protein in Bcl-2 overexpressing MCF-7 breast cancer cells.
    Tophkhane, Chaitali J.
    Yang, Shihe
    Thor, Ann D.
    Yang, Xiao He
    CANCER RESEARCH, 2006, 66 (08)
  • [7] A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
    Wang, Liang
    Chan, Judy Y.
    Zhou, Xinhua
    Cui, Guozhen
    Yan, Zhixiang
    Wang, Li
    Yan, Ru
    Di, Lijun
    Wang, Yuqiang
    Hoi, Maggie P.
    Shan, Luchen
    Lee, Simon M.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [8] Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7
    Leung, LK
    Wang, TTY
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 387 - 392
  • [9] Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7
    L K Leung
    T T Y Wang
    British Journal of Cancer, 1999, 81 : 387 - 392
  • [10] Basic fibroblast growth factor downregulates bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells
    Wang, Q
    Maloof, P
    Wang, HS
    Fenig, E
    Stein, D
    Nichols, G
    Denny, TN
    Yahalom, J
    Wieder, R
    EXPERIMENTAL CELL RESEARCH, 1998, 238 (01) : 177 - 187
12345